Menu
Not yet recruiting NCT07583693

HBM-Based Intervention on Cancer Screening

No phase Interventional Cancer Screening Health Belief Model Attitude Perception

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: HBM-Based İntervention on Cancer Screening.
Who it may be relevant to
Registry conditions: Cancer Screening, Health Belief Model, Attitude, Perception. Basic parameters: 30 years — 70 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Health Belief Model-Based Intervention on Women's Perceptions and Attitudes Toward Cancer Screening: A Quasi-Experimental Study

Overview

The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not undergo regular screenings. The study will be conducted in two family centers, which will be assigned to intervention and control groups using a lottery method. The intervention group will receive a single-session group education, followed by weekly SMS reminders encouraging screening for two weeks. The control group will receive no additional intervention and will continue with standard care. Data will be collected simultaneously from both groups at three points: before the education, immediately after the education, and one month post-intervention.

Interventions

  • Behavioral HBM-Based İntervention on Cancer Screening
    The intervention group will receive a single-session group education lasting 45 minutes. The educational session will be supported by visual presentations, demonstrations on anatomical models, question-and-answer sessions, and group discussions. The curriculum covers the importance of early diagnosis and specific screening methods for breast, cervical, and colorectal cancers. Following the session, participants will receive motivational SMS reminders once a week for two consecutive weeks. These

Primary outcome measures

  • Attitudes Toward Cancer Screening as measured by the Attitudes Toward Cancer Screening Scale [Time frame: 1 month post-education]
  • Perceived Severity of Cancer Subscale of the Cancer Screening Perception Scale [Time frame: 1 month post-education]
  • Perceived Susceptibility Subscale of the Cancer Screening Perception Scale [Time frame: 1 month post-education]
  • Perceived Benefits Subscale of the Cancer Screening Perception Scale [Time frame: 1 month post-education]
  • Perceived Barriers Subscale of the Cancer Screening Perception Scale [Time frame: 1 month post-education]
  • Cues to Action Subscale of the Cancer Screening Perception Scale [Time frame: 1 month post-education]
Secondary outcome measures (1)
  • Cancer Screening Participation Rate [Time frame: 1 month post-education]

Eligibility criteria

Inclusion criteria

  • Being female
  • Being between the ages of 30 and 70
  • Being able to communicate in Turkish
  • Not having undergone regular cancer screenings

Exclusion criteria

  • Having a previous diagnosis of any type of cancer
  • Being under medical follow-up for suspected cancer
  • Having cognitive impairment that prevents effective communication

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Turkey (Türkiye) · 1 center
  • Lokman Hekim Universty — Ankara

Identifiers

NCT: NCT07583693 · LokmanHekimU-Hem-NO-04

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗